Whether an employer is using lab testing or rapid on site drug tests, the answer is the same: it is not included
To meet the diagnostic criteria for dEDS, a person must meet: Major criterion 1 AND major criterion 2 AND at least one other major criterion OR Major criterion 1 AND major criterion 2 AND at least three minor criteria Major Criteria Extreme skin fragility with congenital or postnatal skin tears Characteristic craniofacial features, which are evident at birth or early infancy or evolve later in childhood Redundant, almost lax skin, with excessive skin folds at the wrists and ankles Increased palmar wrinkling Severe bruisability with a risk of subcutaneous hematomas and hemorrhage Umbilical hernia Postnatal growth retardation Short limbs, hands, and feet Perinatal complications due to connective tissue fragility Minor Criteria Soft and doughy skin texture Skin hyperextensibility Atrophic scars Generalized joint hypermobility Complications of visceral fragility (e.g., bladder rupture, diaphragmatic rupture, rectal prolapse) Delayed motor development Osteopenia Hirsutism Tooth abnormalities Refractive errors (myopia, astigmatism) Strabismus Kyphoscoliotic EDS (kEDS) If a person meets the diagnostic criteria for kEDS, genetic testing should be done to confirm the diagnosis
Where to Get GLOW MIX Peptide Therapy in New York GoalBMI Wellness 347-407-7611 Telehealth available across all of New York State Patients across Brooklyn, Queens, the Bronx, Manhattan, Staten Island, Long Island, Buffalo, Rochester, Albany, Syracuse, Yonkers, and surrounding New York communities may discuss GLOW Mix peptide therapy through secure telehealth consultations
Prescription-based treatments like Semaglutide are changing the conversation by giving patients science-backed tools to support lasting results
Complete a COSHH Assessment Assess exposure, controls, storage, emergency procedures and waste
